Evercore ISI lowered the firm’s price target on Henry Schein (HSIC) to $90 from $100 and keeps an Outperform rating on the shares. The firm made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSIC:
- Henry Schein to reduce size of board of directors following annual meeting
- Henry Schein price target raised to $97 from $79 at Barrington
- Henry Schein price target raised to $104 from $100 at Baird
- Henry Schein price target raised to $87 from $79 at UBS
- Henry Schein price target raised to $100 from $90 at Evercore ISI